Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Andrographolide - A potential anti-prostate cancer agent. Edition No. 1

VDM Publishing House, Nov 2009, Pages: 220


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Andrographis paniculata, locally known as “hempedu bumi”, is a small shrub that grows abundantly in Southeast Asia. It is widely used for the treatment of diabetes, rheumatism, hypertension and dysentery. The bitter taste is due to andrographolide, a furano diterpene that exerts most of the biological poperties. Prostate cancer is the second leading cause of male cancer deaths after lung cancer among American men. Selective cytotoxicity, a concept of killing cancer cells while sparing normal cells, is the Holy Grail in cancer treatment. As part of our search for selective cytotoxic compounds from local plants, andrographolide extracted from A. paniculata was found to be selectively cytotoxic against postate cancer (PC-3) cells without significant toxicity to normal cells. To the best of author's knowledge, this is the first study that demonstrates the morphological and biochemical changes occurring in PC-3 cells after treatment with andrographolide. In particular, the results suggested that andrographolide-induced cell death in PC-3 cells was achieved through the apoptotic pathway, via the activation of an extrinsic caspase cascade.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds